Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Showing 9976 - 10000 of >10,000
Lung Cancer, Survivorship Trial in Hull (ExerciseGuide Intervention Group)
Completed
- Lung Cancer
- Survivorship
- ExerciseGuide Intervention Group
-
Hull, East Riding Of Yorkshire, United KingdomQueen's Centre for Oncology and Haematology (Castle Hill)
Oct 31, 2022
Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage
Recruiting
- Metastatic or Locally Advanced Unresectable Solid Tumors
- M1774
- +2 more
-
Houston, Texas
- +4 more
Jul 7, 2022
Risk Communication Within Mexican-American Families
Completed
- Breast Cancer
- +3 more
- Family Health History
-
Houston, TexasMD Anderson Cancer Center
Jan 13, 2023
NSCLC, Primary Tumor Trial in Hamilton (Synapse 3D Lung Modelling, IC-Green (ICG))
Recruiting
- Non-small Cell Lung Cancer
- Primary Neoplasm
- Synapse 3D Lung Modelling
- IC-Green (ICG)
-
Hamilton, Ontario, CanadaSt. Josephs Healthcare Hamilton
Jan 23, 2023
Estrogen Receptor-Positive Breast Carcinoma Trial in Rochester (dietary supplement, drug, other)
Not yet recruiting
- Estrogen Receptor-Positive Breast Carcinoma
- Mushroom
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 31, 2023
Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)
Completed
- Breast Cancer
- anthracycline-based
- +3 more
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022
Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)
Not yet recruiting
- Recurrent Ovarian Cancer
-
Pittsburgh, PennsylvaniaMagee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023
Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)
Not yet recruiting
- Breast Neoplasm
- Trilaciclib plus chemotherapy
- Chemotherapy
- (no location specified)
May 8, 2023
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022
Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)
Not yet recruiting
- Lung Cancer
- Hypofractionated accelerated radiation therapy
-
Palo Alto, CaliforniaStanford University
Oct 11, 2023
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Berkeley
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Cobalamin
- +8 more
-
Birmingham, Alabama
- +349 more
Oct 18, 2022
Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25
Not yet recruiting
- Breast Cancer
- +2 more
- Control Arm ACSM Guidelines
- Experimental Arm 6-12-25 repetitions per set
- (no location specified)
Nov 6, 2023
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Not yet recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan Trial (18F-PMPBB3 (APN-1607) PET imaging)
Recruiting
- Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
- 18F-PMPBB3 (APN-1607) PET imaging
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 24, 2022
Prostate Cancer, Prostate Tumor Trial in Winston-Salem (Blood draws, Magnetic resonance imaging (MRI))
Withdrawn
- Prostate Cancer
- Prostate Tumor
- Blood draws
- Magnetic resonance imaging (MRI)
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Nov 17, 2021
Cancer Patients' Diagnostic and Management: Set-up of Indicators
Recruiting
- Hepatocellular Carcinoma
- Peritoneal Carcinoma
- COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
-
Pierre-Bénite, FranceHopital Lyon sud, Hospices civils de Lyon
Jul 7, 2023
C. Difficile Infection, Cancer Trial in New York (Fecal Microbiota Transplantation (FMT))
Active, not recruiting
- C. Difficile Infection
- Cancer
- Fecal Microbiota Transplantation (FMT)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 26, 2022
Lung Cancer Trial in Australia, Canada, United States (lobectomy, segmentectomy or wedge resection)
Active, not recruiting
- Lung Cancer
- lobectomy
- segmentectomy or wedge resection
-
Birmingham, Alabama
- +385 more
Nov 17, 2022
Head and Neck Squamous Cell Carcinoma Trial in Pittsburgh (duvelisib, pembrolizumab)
Suspended
- Head and Neck Squamous Cell Carcinoma
- duvelisib
- pembrolizumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 15, 2021
Gastrointestinal Cancer Trial in Beijing (Intravenous injection of 68Ga-PMD22)
Recruiting
- Gastrointestinal Cancer
- Intravenous injection of 68Ga-PMD22
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jun 30, 2023
Prostate Cancer Trial in Canada (hypofractionation, conventional)
Unknown status
- Prostate Cancer
- hypofractionation
- conventional
-
Saint John, New Brunswick, Canada
- +11 more
Oct 19, 2020
Fatigue, Sleep and Quality of Life in Parkinson's Patients
Recruiting
- Idiopathic Parkinson's Disease
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 18, 2023
Breast Cancer Trial in Villejuif (Atezolizumab Injection, Ipatasertib, Bevacizumab)
Recruiting
- Breast Cancer
- Atezolizumab Injection
- +4 more
-
Villejuif, FranceGustave Roussy
Mar 9, 2022